The treatment of normal human epidermal keratinocytes with EGCG in vitro was found to inhibit UVB-induced intracellular release of hydrogen peroxide concomitantly with the inhibition of UVB-induced oxidative stress-mediated phosphorylation of epidermal growth factor receptor and mitogen-activated protein kinases (MAPK) signaling pathways